Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Recommendations for the use of CLASI as an outcome measure in cutaneous lupus erythematosus clinical trials.
Journal: Nature reviews. Rheumatology
Published: December 19, 2025
Application of Bayesian statistics to support approval of intravenous belimumab in children with systemic lupus erythematosus in the United States.
Journal: Lupus
Published: June 27, 2025
Model-Informed Drug Development-Based Approval of Intravenous Secukinumab for the Treatment of Adult Patients with Active Psoriatic Arthritis, Active Ankylosing Spondylitis, and Active Non-Radiographic Axial Spondyloarthritis.
Journal: Clinical pharmacology and therapeutics
Published: February 12, 2024
American College of Rheumatology and Food and Drug Administration Summit: Summary of the Meeting, May 17-18, 2022.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: January 26, 2024
Using Machine Learning to Determine a Suitable Patient Population for Anakinra for the Treatment of COVID-19 Under the Emergency Use Authorization.
Journal: Clinical pharmacology and therapeutics
Published: October 24, 2023
Therapeutic Development in Polyarticular Course Juvenile Idiopathic Arthritis: Extrapolation, Dose Selection, and Clinical Trial Design.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: March 15, 2023
Reflections from the OARSI 2022 clinical trials symposium: The pain of OA-Deconstruction of pain and patient-reported outcome measures for the benefit of patients and clinical trial design.
Journal: Osteoarthritis and cartilage
Published: October 08, 2022
FDA/Arthritis Foundation osteoarthritis drug development workshop recap: Assessment of long-term benefit.
Journal: Seminars in arthritis and rheumatism
Published: June 08, 2022
UV absorption by silicate cloud precursors in ultra-hot Jupiter WASP-178b.
Journal: Nature
Published: September 20, 2021
Response Similarity Assessment Between Polyarticular Juvenile Idiopathic Arthritis and Adult Rheumatoid Arthritis for Biologics.
Journal: Clinical pharmacology and therapeutics
Published: November 03, 2020
Inhibition of miR-99a-5p prevents allergen-driven airway exacerbations without compromising type-2 memory responses in the intestine following helminth infection.
Journal: Mucosal immunology
Published: September 14, 2020
Last Updated: 09/26/2026